J&J on track to roll out single-shot Covid-19 vaccine in March, Paul Stoffels confirms, although manufacturing delays raise questions
We should know how effective J&J’s Covid-19 vaccine — the single shot that’s closest to potential authorization — is by the end of this month or early February.
CSO Paul Stoffels added that they are on track to roll out the vaccine in March, just as the pharma giant published Phase I/IIa results in the New England Journal of Medicine. But a New York Times report also raises doubts about how many it can actually deliver in spring, citing unanticipated manufacturing delays.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 98,400+ biopharma pros reading Endpoints daily — and it's free.